Biotrial
Phase 2Biotrial is a CRO specialized in drug development conducting preclinical and clinical studies for biotech pharma companies.
Founded
1989
Focus
Clinical Research
About
Biotrial is a CRO specialized in drug development conducting preclinical and clinical studies for biotech pharma companies.
Pipeline Snapshot
77 drugs in pipeline
| Drug | Indication | Stage |
|---|---|---|
| EXS21546 | Advanced Solid Tumours | Phase 1/2 |
| Phase 1, SQY51 + Phase 2a, SQY51 (cohort 1) + Phase 2a, SQY51 (cohort 2) + Phase... | Duchenne Muscular Dystrophy | Phase 1/2 |
| ITF2357 | Hepatic Impairment | Phase 1 |
| LPH-5 + Placebo | Safety Issues | Phase 1 |
| Binimetinib 15 MG + Binimetinib 45 MG | Melanoma | Phase 1 |
Funding History
4Total raised: $56M
Debt$15MBNP ParibasMay 15, 2022
Debt$8MSociété GénéraleJun 15, 2021
Grant$8MEuropean CommissionJun 15, 2019
Series B$25MBpifranceJun 15, 2019
Company Info
TypePrivate
Founded1989
LocationRennes, France
StagePhase 2
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile